Three things to know:
1. The registration allows BioFirma to package, process, store, label and distribute human cells and tissue.
2. IMAC began using BioFirma’s NeoCyte regenerative medicine products in its rehabilitation clinics.
3. BioFirma now sells amniotic fluid exosomes to physicians in the U.S. and reported $80,000 from the product’s sales during the second quarter of 2019.
More articles on biologics:
Misonix ultrasonic device earns CE Mark approval — 4 insights
Laser Spine Institute co-founders now owe ex-business partner $300M+, judge rules
Academic panel to define best practices for outpatient stem cell procedure
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
